Opportunity gained, opportunity lost: treating pharmacoresistant epilepsy in children

Area of Science:

• Pediatric Neurology
• Developmental Neuroscience
• Epileptology

Background:

• Childhood epilepsy poses risks to cognitive, social, and developmental milestones.
• Ongoing seizures can lead to lasting deficits in education and adult employment.
• Pharmacoresistant epilepsy in children requires specialized, timely medical attention.

Purpose of the Study:

• To emphasize the critical need for early recognition and intervention in pediatric pharmacoresistant epilepsy.
• To highlight the importance of pursuing seizure freedom as the primary treatment goal.
• To advocate for comprehensive evaluation and state-of-the-art treatments for all children with refractory epilepsy.

Main Methods:

• This study is a review of current understanding and treatment paradigms for pediatric epilepsy.
• It synthesizes evidence on the long-term consequences of untreated or undertreated childhood epilepsy.
• It emphasizes the role of specialized pediatric epilepsy centers in management.

Main Results:

• Seizure freedom is achievable and crucial for mitigating long-term developmental and functional impairments.
• Even low probabilities of seizure freedom should not deter aggressive treatment strategies.
• Comprehensive evaluation at specialized centers is essential for optimizing care.

Conclusions:

• Early and aggressive management of pediatric pharmacoresistant epilepsy is vital.
• Specialized pediatric epilepsy centers offer the best approach for state-of-the-art treatment.
• Failure to provide optimal care exacerbates the burden of epilepsy on children and families.